Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
BMC Ophthalmol ; 16: 44, 2016 Apr 21.
Article in English | MEDLINE | ID: mdl-27102524

ABSTRACT

BACKGROUND: In Nigeria, glaucoma has a high prevalence and is the second cause of blindness among adults after cataract. People with glaucoma frequently present very late with advanced disease, and acceptance of and adherence to treatment is low. The purpose of the study was to explore how patients' understand and respond to glaucoma in order develop an intervention to improve adherence to treatment. METHOD: Hospital based qualitative study. Six focus group discussions were held with patients with advanced disease and who had either undergone glaucoma surgery, were receiving medical treatment, or had neither surgery nor medical treatment. Two traditional healers who treat eye conditions were interviewed. Audio files were transcribed, translated into English and recurring themes coded and categorized as the impact of vision loss, and understandings of the disease and its management. RESULTS: Visual loss impacted significantly on the lives of people with glaucoma in many ways. Many heard the term "glaucoma" for the first time during the study. Local terms to describe the symptoms included Hawan jinin ido ("hypertension of the eye"). Patients sought treatment in pharmacies, or with traditional healers who had different interpretations of glaucoma and its treatment to biomedical understandings. Cost and forgetfulness were the main reasons for low adherence to treatment while fear was a reason for not accepting surgery. Lack of money and negative staff attitudes were reasons for low follow up. CONCLUSION: Halting the progression of glaucoma is possible with treatment but the condition will remain a "silent thief of sight" in West Africa unless awareness, uptake of services and adherence to treatment improve. Understanding how glaucoma is locally conceptualised, lived with and responded to by patients is essential to aid the design of interventions to prevent glaucoma blindness in Africa. Findings have been used to adapt a motivational interviewing intervention, which is being evaluated in a clinical trial.


Subject(s)
Glaucoma/psychology , Glaucoma/therapy , Health Behavior , Health Knowledge, Attitudes, Practice , Patient Acceptance of Health Care/psychology , Patients/psychology , Antihypertensive Agents/therapeutic use , Female , Filtering Surgery , Glaucoma/epidemiology , Health Services Accessibility , Humans , Intraocular Pressure , Male , Nigeria/epidemiology , Patient Compliance , Rural Population , Visual Acuity
2.
Asia Pac J Ophthalmol (Phila) ; 7(6): 375-386, 2018.
Article in English | MEDLINE | ID: mdl-30574693

ABSTRACT

Glaucoma is a serious and irreversibly blinding eye condition of public health importance in Africa. The absence of distinct early symptoms makes the condition hard to recognize by patients. The gradual vision deterioration that occurs is worse in one eye, thereby making it difficult for those affected to be aware of the vision loss until the advanced stages of the disease. We discuss the epidemiology of glaucoma in sub-Saharan Africa, highlighting the risk factors for the disease as well as risk factors for blindness in glaucoma patients. Available evidence suggests that treatment options of medical, surgical, and laser therapies for glaucoma are limited by availability of medicines and equipment, lack of adequate surgical and diagnostic skills, and high costs of treatment. We propose 3 complementary strategies in developing models of glaucoma care: strengthening clinical services for glaucoma; earlier detection of glaucoma in the clinics and communities; and strengthening health systems governance. Further research to define a suitable cost-beneficial treatment modality and mechanisms for financing eye care is required.


Subject(s)
Delivery of Health Care/organization & administration , Glaucoma/epidemiology , Glaucoma/therapy , Health Services Accessibility/organization & administration , Africa South of the Sahara/epidemiology , Blindness/prevention & control , Humans , Ophthalmologic Surgical Procedures , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL